We use cookie to improve your experience on our site. By using our site you consent cookies. Learn more
Fill in the form to get detailed information and make an appointment, we will contact you.
Robot-assisted radical prostatectomy (RARP) is a gold-standard, minimally invasive oncological procedure performed using the da Vinci surgical system for the definitive surgical management of localized and locally advanced prostate cancer. The surgery entails the precise en bloc excision of the prostate gland, seminal vesicles, and ampullary vas deferens, followed by a watertight vesicourethral anastomosis and bilateral pelvic lymph node dissection when indicated.
At Gözde International Hospitals, our fellowship-trained robotic uro-oncologists combine high-magnification 3D stereoscopic visualization, wristed articulation, and advanced neurovascular-sparing techniques to maximize oncological cure while prioritizing early return of urinary continence and sexual potency.
Traditional open radical retropubic prostatectomy requires a large lower abdominal incision to access the deep, narrow confines of the male pelvis. In contrast, RARP is conducted through miniature ports under pneumatic pressure (pneumoperitoneum), which naturally suppresses venous bleeding from the dorsal venous complex (Santorini's plexus). The robotic platform translates the surgeon's finger and wrist maneuvers into tremor-filtered, micro-scaled movements inside the pelvic cavity.
Core surgical elements include:
Neurovascular Bundle Preservation (Nerve-Sparing Technique): Using cold-scissor micro-dissection and avoiding thermal energy near the lateral pelvic fascia, the cavernous autonomic nerves responsible for erectile function are spared in candidate patients without compromising cancer clearance.
Preservation of the External Urethral Sphincter: Maximizing functional urethral length and preserving the anterior and posterior pelvic fascial suspension structures (Rocco stitch and anterior reconstruction) to facilitate rapid return of urinary continence.
Watertight Vesicourethral Anastomosis: A continuous running micro-suture reconnects the bladder neck directly to the preserved urethral stump over a silicone Foley catheter, ensuring a tension-free, leak-proof seal.
The clinical procedure delivers two fundamental outcomes:
Complete Oncological Clearance: Negative surgical margins and thorough pelvic lymphadenectomy provide reliable local cancer eradication and accurate pathological grading.
Functional Anatomy Preservation: Significantly accelerates postoperative continence recovery and improves post-treatment erectile potency compared to conventional open surgery.
Minimal Intraoperative Blood Loss: Pneumoperitoneum and precise micro-coagulation minimize hemorrhage, virtually eliminating the need for blood transfusions.
Enhanced Visual Acuity: 10x magnified, true-depth 3D HD cameras allow distinct visualization of microscopic nerves, fascial planes, and tissue boundaries.
Reduced Postoperative Pain: Small 8 to 12 mm keyhole port incisions cause minimal muscle trauma, significantly lowering the requirement for narcotic pain relievers.
Shorter Hospitalization and Convalescence: Most patients are discharged within 24 to 48 hours and return to sedentary routines within 1 to 2 weeks.
Patients diagnosed with clinically localized prostate cancer (stages cT1c to cT2c, Gleason scores 6 to 10, PSA up to 20 ng/mL or higher within high-risk paradigms).
Select patients with locally advanced prostate cancer (stage cT3a) undergoing multimodal oncological management.
Individuals with a life expectancy greater than 10 years seeking definitive surgical eradication of malignant disease.
Patients who prioritize early continence restoration and the preservation of erectile potency through nerve-sparing approaches.
Candidates with adequate cardiopulmonary capacity to tolerate general anesthesia and prolonged steep Trendelenburg positioning.
Preoperative Staging and Planning: Multiparametric prostate MRI (mpMRI), PET-PSMA imaging, and 3D reconstruction map tumor localization, extracapsular extension risk, and neurovascular proximity.
Anesthesia and Positioning: General anesthesia with steep Trendelenburg positioning to displace the bowel cephalad away from the prostatic bed.
Robotic Port Insertion and Docking: Five to six small ports are placed across the mid-abdomen, and the da Vinci Xi robotic arms are positioned.
Extirpation and Reconstruction: The space of Retzius is developed, the endopelvic fascia is incised, the bladder neck is preserved, the seminal vesicles and prostate are dissected, pelvic lymph nodes are cleared if indicated, and the vesicourethral anastomosis is completed.
Duration: The operative procedure typically requires 120 to 180 minutes.
A structured enhanced recovery pathway promotes rapid and predictable rehabilitation:
Early Mobilization: Ambulation begins on the day of surgery or within the first 24 hours to stimulate gastrointestinal motility and prevent venous thromboembolism.
Catheter Care: The transurethral Foley catheter remains in place for 7 to 10 days to protect the healing bladder-urethra junction, after which it is removed following a cystogram or standard clinical check.
Continence Rehabilitation: Daily pelvic floor muscle training (Kegel exercises) begins immediately after catheter removal, with most patients regaining continence within weeks to a few months.
Oncological Surveillance: Serum PSA testing is conducted at 6 weeks, 3 months, 6 months, and annually thereafter; achieving an undetectable PSA ($< 0.1$ or $< 0.05$ ng/mL) confirms biochemical remission.
Specialized Robotic Uro-Oncologists: High-volume surgeons dedicated to nerve-sparing prostatectomy and complex pelvic oncological reconstructions.
State-of-the-Art da Vinci Xi Technology: Multi-quadrant surgical architecture with high-definition optical magnification and wristed micro-instruments.
Holistic Post-Prostatectomy Support: Specialized physiotherapists for pelvic floor rehabilitation, alongside dedicated andrological programs for sexual recovery.
All-Inclusive VIP Concierge Services: Private airport transfers, companion-friendly deluxe hospital suites, dedicated multilingual patient coordinators, and ongoing remote follow-up.
Robot-assisted radical prostatectomy is a minimally invasive surgery performed using the da Vinci robotic system to completely excise the cancerous prostate gland, seminal vesicles, and regional pelvic lymph nodes, serving as the gold standard curative treatment for localized prostate cancer.
The 3D high-magnification robotic vision and micro-articulated instruments allow delicate preservation of the millimeter-thin cavernous neurovascular bundles running directly along the prostate capsule, significantly accelerating the recovery of spontaneous erections when oncologically safe.
By providing clear visualization of the apex of the prostate and pelvic floor musculature, the robotic technique maximizes urethral length preservation and allows precise anatomical reconstruction of the rhabdosphincter (Rocco stitch), leading to rapid postoperative continence recovery.
Patients mobilize on the day of surgery and are typically discharged within 1 to 2 days. The urinary catheter remains in place for 6 to 10 days to allow the urethrovesical anastomosis to seal watertight, with return to sedentary work in 2 to 3 weeks.
Oncological success is defined by clear surgical margins (R0) and an undetectable serum PSA level (<0.1 ng/ml or <0.02 ng/ml in ultrasensitive testing) measured at 6 weeks post-surgery, followed by routine PSA surveillance every 3 months for the first year.
If you would like to receive a quote or more information, please fill out the "GET INFORMATION" form on the side, send us an email or send us a message on WhatsApp!